
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10932031
[patent_doc_number] => 20140335050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/122531
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 72940
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122531 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | May 24, 2012 | Abandoned |
Array
(
[id] => 8866015
[patent_doc_number] => 20130149718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'METHODS OF DETERMINING CELLULAR CHEMOSENSITIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/478831
[patent_app_country] => US
[patent_app_date] => 2012-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 16763
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478831
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/478831 | Methods of determining cellular chemosensitivity | May 22, 2012 | Issued |
Array
(
[id] => 8696932
[patent_doc_number] => 20130058940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis'
[patent_app_type] => utility
[patent_app_number] => 13/476936
[patent_app_country] => US
[patent_app_date] => 2012-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26466
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13476936
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/476936 | Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis | May 20, 2012 | Abandoned |
Array
(
[id] => 8495880
[patent_doc_number] => 20120295288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'SEROLOGICAL MARKER FOR DETECTING PANCREATIC CANCER AND A METHOD FOR USING THE SEROLOGICAL MARKER'
[patent_app_type] => utility
[patent_app_number] => 13/475658
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3579
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475658
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475658 | SEROLOGICAL MARKER FOR DETECTING PANCREATIC CANCER AND A METHOD FOR USING THE SEROLOGICAL MARKER | May 17, 2012 | Abandoned |
Array
(
[id] => 9823711
[patent_doc_number] => 08933196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-13
[patent_title] => 'Peptide chromatographic purification assisted by combining of solubility parameter and solution conformation energy calculations'
[patent_app_type] => utility
[patent_app_number] => 13/472152
[patent_app_country] => US
[patent_app_date] => 2012-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5379
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472152
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/472152 | Peptide chromatographic purification assisted by combining of solubility parameter and solution conformation energy calculations | May 14, 2012 | Issued |
Array
(
[id] => 9060116
[patent_doc_number] => 08546551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Method to detect prostate cancer in a sample'
[patent_app_type] => utility
[patent_app_number] => 13/470451
[patent_app_country] => US
[patent_app_date] => 2012-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16753
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470451
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470451 | Method to detect prostate cancer in a sample | May 13, 2012 | Issued |
Array
(
[id] => 9698612
[patent_doc_number] => 20140248297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'PREDICTORS OF RESPONSE TO IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/117322
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5631
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117322
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117322 | PREDICTORS OF RESPONSE TO IMMUNOTHERAPY | May 10, 2012 | Abandoned |
Array
(
[id] => 9463281
[patent_doc_number] => 20140127708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'PREDICTIVE BIOMARKERS FOR PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/115430
[patent_app_country] => US
[patent_app_date] => 2012-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 48217
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115430
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/115430 | PREDICTIVE BIOMARKERS FOR PROSTATE CANCER | May 7, 2012 | Abandoned |
Array
(
[id] => 8370598
[patent_doc_number] => 20120219982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'METHODS FOR SELECTING ACTIVE AGENTS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 13/461079
[patent_app_country] => US
[patent_app_date] => 2012-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8923
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461079
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/461079 | METHODS FOR SELECTING ACTIVE AGENTS FOR CANCER TREATMENT | Apr 30, 2012 | Abandoned |
Array
(
[id] => 9330107
[patent_doc_number] => 20140056889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/113575
[patent_app_country] => US
[patent_app_date] => 2012-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 71302
[patent_no_of_claims] => 91
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113575 | COMPOSITIONS AND METHOD FOR TREATING AUTOIMMUNE DISEASES | Apr 25, 2012 | Abandoned |
Array
(
[id] => 8431145
[patent_doc_number] => 20120253020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways'
[patent_app_type] => utility
[patent_app_number] => 13/454642
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 22887
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454642 | Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways | Apr 23, 2012 | Abandoned |
Array
(
[id] => 8932406
[patent_doc_number] => 08492104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Methods and kits to detect and monitor ovarian cancer and preeclampsia'
[patent_app_type] => utility
[patent_app_number] => 13/454276
[patent_app_country] => US
[patent_app_date] => 2012-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13869
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454276
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/454276 | Methods and kits to detect and monitor ovarian cancer and preeclampsia | Apr 23, 2012 | Issued |
Array
(
[id] => 8495877
[patent_doc_number] => 20120295286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Methods for the Diagnosis, Prognosis and Monitoring of Cancer Therapy Using BP1'
[patent_app_type] => utility
[patent_app_number] => 13/453432
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6539
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453432
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/453432 | Methods for the Diagnosis, Prognosis and Monitoring of Cancer Therapy Using BP1 | Apr 22, 2012 | Abandoned |
Array
(
[id] => 8779623
[patent_doc_number] => 20130101599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/450716
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13565
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450716
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450716 | BCMA-BASED STRATIFICATION AND THERAPY FOR MULTIPLE MYELOMA PATIENTS | Apr 18, 2012 | Abandoned |
Array
(
[id] => 8370117
[patent_doc_number] => 20120219502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32'
[patent_app_type] => utility
[patent_app_number] => 13/448820
[patent_app_country] => US
[patent_app_date] => 2012-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 38240
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448820
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448820 | METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32 | Apr 16, 2012 | Abandoned |
Array
(
[id] => 9016508
[patent_doc_number] => 20130231472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'USE OF MOLECULAR MARKERS FOR THE PRECLINICAL PROFILING OF INHIBITORS OF ENZYMES HAVING HISTONE DEACETYLASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/447797
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11732
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13447797
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/447797 | USE OF MOLECULAR MARKERS FOR THE PRECLINICAL PROFILING OF INHIBITORS OF ENZYMES HAVING HISTONE DEACETYLASE ACTIVITY | Apr 15, 2012 | Abandoned |
Array
(
[id] => 8335110
[patent_doc_number] => 20120201817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/445239
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8043
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445239
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445239 | METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST | Apr 11, 2012 | Abandoned |
Array
(
[id] => 8721212
[patent_doc_number] => 20130072429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'ASSAYS AND METHODS USING BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/444500
[patent_app_country] => US
[patent_app_date] => 2012-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 29628
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13444500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/444500 | ASSAYS AND METHODS USING BIOMARKERS | Apr 10, 2012 | Abandoned |
Array
(
[id] => 8394130
[patent_doc_number] => 20120231966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'LUNG CANCER DIAGNOSTIC ASSAY'
[patent_app_type] => utility
[patent_app_number] => 13/430474
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15755
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430474
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/430474 | LUNG CANCER DIAGNOSTIC ASSAY | Mar 25, 2012 | Abandoned |
Array
(
[id] => 10008111
[patent_doc_number] => 09051619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-09
[patent_title] => 'Methods and compositions for prostate cancer metastasis'
[patent_app_type] => utility
[patent_app_number] => 13/428750
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 16141
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/428750 | Methods and compositions for prostate cancer metastasis | Mar 22, 2012 | Issued |